Literature DB >> 11081785

Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive Therapy.

E Ambrosioni1, G Leonetti, A C Pessina, A Rappelli, B Trimarco, A Zanchetti.   

Abstract

OBJECTIVE: To collect statistically significant information on patterns of antihypertensive therapy in medical practice, with particular attention to the drugs used in the pharmacological management of hypertensive patients and the reasons for the limited achievement of therapeutic goals during treatment
DESIGN: A survey conducted among general practitioners, specialists, and hypertensive patients.
METHODS: A total of 28,000 physicians were contacted by letter and 3,394 declared their willingness to participate and received a questionnaire. Subsequently, 1,255 questionnaires suitable for analysis (corresponding to 37.0% of adhering physicians) were received. In addition, 4,612 questionnaires completed by patients were pooled and evaluated. The prevalence of hypertension was calculated from a base of 254,192 patients, seen by general practitioners.
RESULTS: The prevalence of hypertension, defined as systolic blood pressure > or = 160 mmHg or diastolic blood pressure > or = 95 mmHg, or current treatment, was 19.7%. The average number of hypertensive patients in each general practitioner's file, covering the previous 12 months, was approximately 230. Physicians reported a 66% rate of discontinuation of treatment or switching to another drug. Physicians and patients both considered inadequate blood pressure control and side effects to be the two main reasons for switching antihypertensive therapy, but in opposite order. Furthermore, physicians indicated a prevalence of drug side effects between 10 and 20%, according to class of drug used, whereas 69% of patients reported to have experienced side effects. In the doctors' opinions, there were many reasons for poor patient adherence: complexity of the drug regimen, appearance of side effects, forgetfulness, reduced patient understanding of the need for long-term continuation of treatment, and refusal to accept a chronic pathological condition.
CONCLUSIONS: The survey showed awareness of the disease among physicians and provides a representation of the experiences of both general practitioners and specialists, in addition to that of their patients. During antihypertensive therapy, a disconcerting degree of discontinuation and switching of drugs occurred. Insufficient blood pressure control and side effects accounted for most of the observed treatment changes. This survey revealed the existence of a gap between the physicians' perception of tolerability and the real experience of patients, a clear need for greater tolerability of treatments, and a need for an enhancement of patient-physician communication.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11081785     DOI: 10.1097/00004872-200018110-00023

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  23 in total

1.  Insertion/deletion polymorphism of the ACE gene and adherence to ACE inhibitors.

Authors:  H Schelleman; O H Klungel; C M van Duijn; J C M Witteman; A Hofman; A de Boer; B H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

2.  Safety and tolerability of an olmesartan medoxomil-based regimen in patients with stage 1 hypertension: a randomized, double-blind, placebo-controlled study.

Authors:  Steven G Chrysant
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 3.  Desirable therapeutic characteristics of an optimal antihypertensive agent.

Authors:  Lisa Mustone Alexander
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Compliance with therapy in hypertensive patients.

Authors:  Alfonso Lagi; Antonio Rossi; Maria Teresa Passaleva; Alessandro Cartei; Simone Cencetti
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 5.  Variability in the prescription of cardiovascular medications in older patients: correlates and potential explanations.

Authors:  Cinzia Maraldi; Fabrizia Lattanzio; Graziano Onder; Massimo Gallerani; Silvia Bustacchini; Giuseppe De Tommaso; Stefano Volpato
Journal:  Drugs Aging       Date:  2009-12       Impact factor: 3.923

6.  Financial and health costs of uncontrolled blood pressure in the United Kingdom.

Authors:  Adam Lloyd; Claudia Schmieder; Nick Marchant
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 7.  Effect of antihypertensive agents on quality of life in the elderly.

Authors:  Roberto Fogari; Annalisa Zoppi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 8.  Fixed low-dose combination therapy for hypertension.

Authors:  Bernard Waeber
Journal:  Curr Hypertens Rep       Date:  2002-08       Impact factor: 5.369

Review 9.  Repeat prescribing: scale, problems and quality management in ambulatory care patients.

Authors:  Peter A G M De Smet; Maaike Dautzenberg
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Should blood pressure ≥130/80 mm Hg be considered as a cardiovascular disease?

Authors:  Marijana Tadic; Cesare Cuspidi
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.